Bioavailability

Absolute bioavailability is commonly expressed as F = (AUC oral / Dose oral) ÷ (AUC IV / Dose IV). The “area under the curve” captures total blood exposure over time, while peak concentration and time-to-peak describe how fast that exposure appears. A product can raise the peak quickly without improving total exposure very much, which is one reason “faster” and “more bioavailable” are not always identical.

The same milligrams can arrive like very different deliveries

A supplement bottle says 500 mg. A study headline says the ingredient “worked at 500 mg.” It sounds like a direct match. But bioavailability is the part that ruins that shortcut: the number on the label is the amount you sent, not the amount that actually arrived in your bloodstream.

That is why bioavailability pharmacology matters so much. In medicine and supplement research, the body is not a passive tube. A swallowed substance has to survive stomach acid, dissolve, cross the gut wall, and then pass through the liver before it can circulate widely. Some of it is never absorbed. Some is changed on the first trip through the liver. Some dissolves poorly and misses the ride entirely.

More like mailing powder than pouring water

The surprise is that bioavailability is not mainly about how much is inside the capsule; it is about how much completes the trip intact. Think of a handful of chalk dust dropped onto a moving sidewalk in the rain: some clumps, some blows away, some sticks to the belt, and only part reaches the other end. That is closer to what oral delivery is like than the neat picture most labels imply.

Formally, bioavailability means the rate and extent to which an active ingredient reaches systemic circulation—the bloodstream that can carry it around the body. In bioavailability pharmacokinetics, this is often summarized with blood-level curves over time. The classic bioavailability formula compares exposure after a non-intravenous dose with exposure after an intravenous dose, often using the area under the concentration-time curve, adjusted for dose.

An intravenous dose is treated as 100% bioavailability because it is placed directly into the bloodstream. Oral products are usually lower. “High bioavailability” does not mean “strong” or “best” by itself; it means a larger share gets into circulation under the measured conditions.

Why a better-absorbed product can still disappoint

Bioavailability is not a moral score and not a guarantee of benefit. A form can enter the bloodstream well and still be the wrong dose, the wrong timing, or the wrong ingredient for your goal. And a low-bioavailability substance can still matter if it is taken repeatedly, acts locally in the gut, or is given in a formulation designed to improve delivery.

That is where relative bioavailability becomes useful. Sometimes researchers are not asking, “How much got in versus an IV dose?” They are asking, “Did formulation A get in better than formulation B?” That is how one capsule, tablet, softgel, liposomal form, or food matrix gets compared with another.

One decision to make today

When you read a study or a supplement label, do not match the milligrams first. Match the form and delivery system first. If a study used a highly absorbed form—say curcumin paired with piperine or a specialized phytosome—do not assume a plain powder at the same dose will behave similarly.